🇺🇸 GILD — Gilead Sciences, Inc.

Healthcare Compra
← Volver

Precio actual

151,00 USD

Máx. histórico

157,29

205 días

Caída desde máximo

-4,00%

Rango 52 semanas

108,46 – 157,29

Variación hoy

-0,15%

Cierre anterior

151,22

Rango de hoy

149,23 – 151,19

Volumen hoy

5.977.099

Información
Nombre completo
Gilead Sciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
17.000
PER ⓘ
—
Dividend yield
2,17% (puede no estar actualizado)
Precio objetivo analistas
157,41 USD (puede no estar actualizado)
Primera cotización
22/01/1992
Precio actualizado
hace 2 días
Sobre la empresa

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment of adult patients. Further, it provides AmBisome, for the treatment of serious invasive fungal infections; and Veklury for the treatment of COVID-19. Additionally, the company engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company has collaboration agreements with Shenzhen Pregene Biopharma Co., Ltd.; Abingworth; Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Dividendos repartidos Total últimos 12 meses: 3,2200 USD · Yield: 2,13%
Fecha de pago Importe por participación
15/06/2026 0,8200 USD
13/03/2026 0,8200 USD
15/12/2025 0,7900 USD
15/09/2025 0,7900 USD
13/06/2025 0,7900 USD
14/03/2025 0,7900 USD
13/12/2024 0,7700 USD
13/09/2024 0,7700 USD
14/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7500 USD
14/09/2023 0,7500 USD
14/06/2023 0,7500 USD
14/03/2023 0,7500 USD
14/12/2022 0,7300 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
21/09/2017 82,73 83,41 82,23 82,62 -0,02% 1,43% 6.194.700
20/09/2017 82,36 82,90 81,84 82,64 +0,43% 1,29% 6.355.100
19/09/2017 83,39 83,39 82,13 82,29 -0,82% 1,51% 6.310.500
18/09/2017 82,53 83,50 81,54 82,97 +0,74% 2,37% 7.886.500
15/09/2017 82,79 83,50 82,31 82,36 +0,09% 1,44% 12.401.900
14/09/2017 83,14 83,14 81,57 82,29 -1,66% 1,89% 9.605.400
13/09/2017 84,50 84,51 83,37 83,68 -0,98% 1,35% 7.594.800
12/09/2017 84,15 84,75 83,80 84,51 -0,01% 1,13% 8.907.900
11/09/2017 85,68 86,00 84,14 84,52 -0,68% 2,17% 10.125.200
08/09/2017 85,29 86,27 84,90 85,10 -0,43% 1,61% 11.611.100
07/09/2017 83,12 85,62 82,90 85,47 +3,04% 3,27% 13.147.800
06/09/2017 82,85 83,43 82,51 82,95 +0,47% 1,11% 10.694.600
05/09/2017 83,24 83,62 81,35 82,56 -1,42% 2,73% 13.491.900
01/09/2017 83,36 84,10 82,25 83,75 +0,05% 2,22% 14.311.600
31/08/2017 81,50 84,13 81,47 83,71 +3,05% 3,26% 30.895.700
30/08/2017 75,82 81,44 75,74 81,23 +7,25% 7,52% 35.927.100
29/08/2017 74,29 75,80 74,22 75,74 +1,41% 2,13% 10.688.600
28/08/2017 74,90 75,94 74,20 74,69 +1,22% 2,32% 18.800.000
25/08/2017 74,23 74,43 73,69 73,79 -0,31% 1,00% 3.729.000
24/08/2017 73,81 74,30 73,65 74,02 +0,38% 0,88% 4.929.300
23/08/2017 73,27 74,20 73,06 73,74 +0,55% 1,56% 6.499.300
22/08/2017 72,66 73,76 72,65 73,34 +1,02% 1,53% 4.729.300
21/08/2017 72,08 72,96 72,08 72,60 +0,68% 1,22% 5.531.800
18/08/2017 72,32 72,63 71,83 72,11 -0,32% 1,11% 6.052.600
17/08/2017 73,09 73,41 72,28 72,34 -1,38% 1,55% 9.065.400
16/08/2017 73,19 73,77 73,12 73,35 +0,31% 0,89% 5.237.300
15/08/2017 73,00 73,38 72,73 73,12 +0,43% 0,89% 5.212.100
14/08/2017 72,87 73,11 72,56 72,81 +0,57% 0,75% 4.952.800
11/08/2017 72,52 72,68 71,82 72,40 -0,41% 1,19% 7.029.700
10/08/2017 73,52 73,78 72,53 72,70 -1,62% 1,70% 8.813.000